2-CHLORO-N-(1,5-DIMETHYL-1H-PYRAZOL-3-YL)-ACETAMIDE
|
- $485 - $874
- Product name: 2-CHLORO-N-(1,5-DIMETHYL-1H-PYRAZOL-3-YL)-ACETAMIDE
- CAS: 957510-88-2
- MF: C7H10ClN3O
- MW: 187.63
- EINECS:
- MDL Number:MFCD04968666
- Synonyms:ART-CHEM-BB B017621;AKOS B017621;2-CHLORO-N-(1,5-DIMETHYL-1H-PYRAZOL-3-YL)-ACETAMIDE;TIMTEC-BB SBB010768;2-chloro-N-(1,5-dimethylpyrazol-3-yl)acetamide;Acetamide, 2-chloro-N-(1,5-dimethyl-1H-pyrazol-3-yl)-
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 1G
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0039653
- Product description2-CHLORO-N-(1,5-DIMETHYL-1H-PYRAZOL-3-YL)-ACETAMIDE 95.00%
- Packaging1G
- Price$688.8
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11003153
- Product description2-Chloro-N-(1,5-dimethyl-1H-pyrazol-3-yl)acetamide 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number020138
- Product description2-Chloro-N-(1,5-dimethyl-1H-pyrazol-3-yl)-acetamide
- Packaging1g
- Price$485
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0039653 | 2-CHLORO-N-(1,5-DIMETHYL-1H-PYRAZOL-3-YL)-ACETAMIDE 95.00% | 1G | $688.8 | 2021-12-16 | Buy |
| Crysdot | CD11003153 | 2-Chloro-N-(1,5-dimethyl-1H-pyrazol-3-yl)acetamide 97% | 5g | $874 | 2021-12-16 | Buy |
| Matrix Scientific | 020138 | 2-Chloro-N-(1,5-dimethyl-1H-pyrazol-3-yl)-acetamide | 1g | $485 | 2021-12-16 | Buy |
Properties
Boiling point :372.3±32.0 °C(Predicted)
Density :1.32±0.1 g/cm3(Predicted)
pka :12.07±0.70(Predicted)
Density :1.32±0.1 g/cm3(Predicted)
pka :12.07±0.70(Predicted)
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||
| Precautionary statements: |
|